Delirium in the Elderly - PowerPoint PPT Presentation

1 / 49
About This Presentation
Title:

Delirium in the Elderly

Description:

Delirium in the Elderly Kirsten M. Wilkins, MD Assistant Professor of Psychiatry Yale School of Medicine VA CT Healthcare System Delirium: Management Identification ... – PowerPoint PPT presentation

Number of Views:244
Avg rating:3.0/5.0
Slides: 50
Provided by: OndriaG
Category:

less

Transcript and Presenter's Notes

Title: Delirium in the Elderly


1
Delirium in the Elderly
  • Kirsten M. Wilkins, MD
  • Assistant Professor of Psychiatry
  • Yale School of Medicine
  • VA CT Healthcare System

2
Case 1
  • A 79 year old man with dementia, DMII, CAD, COPD,
    and acute renal failure but no other psychiatric
    history was admitted for pneumonia. After a 3
    week hospital course complicated by delirium,
    hyponatremia, and UTI, he has been less agitated,
    more cooperative and more oriented for 2 days in
    association with decreased wbc and lessened
    oxygen requirements. You are consulted for acute
    suicidal ideation.
  • What initial plan would be best?
  • a. Assign a sitter (11), evaluate patient for
    antidepressant, provide supportive psychotherapy
    to address prolonged hospitalization
  • b. Assign a sitter (11), check urinalysis, do a
    chest x-ray, begin SSRI
  • c. Transfer to psychiatry for further care
  • d. Evaluate for a sitter (11), check
    urinalysis, do a chest x-ray, discuss with
    primary team

3
Case 1 - Discussion
  • Answer D Evaluate for a sitter (11), check
    urinalysis, do a chest x-ray, discuss with
    primary team
  • Delirium must be ruled out first in this caseit
    offers more morbidity than depression in this
    setting and this patient is at higher risk for
    having delirium. Suicidal ideation is common in
    delirium. Adding an antidepressant may worsen the
    picturebetter to wait 2-3 days to rule out
    delirium, as that delay will not greatly impact
    treatment of depression but, misdiagnosing as
    depression may result in failing to search for
    the cause of the delirium.

4
Delirium
  • DSM-IV-TR Criteria
  • Disturbance of consciousness with reduced ability
    to focus, sustain, or shift attention.
  • A change in cognition (memory deficit,
    disorientation, language disturbance) or the
    development of a perceptual disturbance (i.e.
    auditory or visual hallucinations) that is not
    better accounted for by a preexisting dementia.

5
Delirium
  • DSM-IV-TR Criteria, cont.
  • The disturbance develops over a short time
    (hours to days) and fluctuates during the day.
  • There is evidence that the disturbance is caused
    by the direct physiological consequences of a
    general medical condition or substance.

6
Delirium
  • DELIRIUM IS ALSO KNOWN AS.
  • acute confusional state
  • acute mental status change
  • altered mental status
  • brain failure
  • hepatic encephalopathy
  • organic brain syndrome
  • toxic or metabolic encephalopathy

7
Delirium Epidemiology
  • Prevalence depends on population
  • Greater in med/surg population
  • Community 0.4 - 2
  • General hospital admissions 20
  • On admission 10 15 elders
  • During hospitalization up to 40
  • At end of life up to 83
  • Trzepacz and Meagher 2005
  • Saxena and Lawley 2009
  • Fong et al 2009

8
Delirium Epidemiology
  • Higher rates seen with
  • Post-op (ortho, cardiothoracic, vascular)
  • ICU admission
  • Poor functional recovery
  • Increased hospital lengths of stay
  • Increased likelihood of NH placement
  • Up to 60 NH pts have delirium
  • Trzepacz and Meagher 2005
  • Mittal et al 2011

9
Delirium - Impact
  • Increased morbidity
  • Poorer recovery from medical illness
  • Increased need for walking devices
  • 6x increased risk of decubitus ulcers or
    aspiration pneumonia
  • Increased risk of future cognitive decline
  • 10-33 mortality rate in hospital
  • Increased risk of mortality even months after d/c
    Fong
    et al 2009
  • Siddiqi et al 2006

10
(No Transcript)
11
Case 2
  • Consult requested for 85 yo female with h/o
    dementia recently admitted to SNF, following
    hospitalization for hip fracture/repair ,
    complicated by post-op infection. Pt noted by
    staff to be disoriented, sundowning, and
    resistant to care and PT. Per staff, family
    concerned that her dementia is much worse than
    before her surgery despite apparently successful
    surgery and resolution of her infection. Which
    of the following may explain her symptoms?
  • A) Opioid pain medications
  • B) Ongoing symptoms of delirium
  • C) New cognitive baseline
  • D) Old age
  • E) A, B, and C

12
Delirium Risk Factors
  • Age
  • Preexisting dementia
  • Recent surgery
  • Bone fractures
  • Infections
  • Hypoalbuminemia
  • Preexisting CNS structural abnormalities

13
Delirium Risk Factors
  • Abnormal sodium
  • Severe illness
  • AIDS, Cancer
  • Polypharmacy
  • Dehydration
  • Visual/hearing impairment

14
Delirium Risk Factors
  • Substance Abuse
  • Alcohol
  • Prescription drugs
  • Illicit drugs
  • You must ask!
  • Collateral informant

15
Delirium Presentation
  • Three types
  • Hyperactive
  • Better recognized
  • More attention to treatment
  • Associated with improved outcome
  • Hypoactive
  • Little recognized
  • Depression is primary differential
  • Associated with poor outcomes
  • Mixed

16
Delirium Presentation
  • Cognitive Symptoms
  • Inattention
  • Memory impairment
  • Disorientation
  • Behavioral Symptoms
  • Agitation or hypoactivity
  • Resistance to care
  • Sleep-wake disturbance
  • Psychiatric Symptoms
  • Paranoia, delusions
  • Hallucinations (often visual), illusions
  • Affective lability

17
Disrupted Sleep-wake Cycle
  • Insomnia
  • Napping
  • Being awake at night, limited light and external
    cues leads to disorientation and paranoia which
    may cause agitation
  • Caution with sedative medications due to concerns
    of worsening delirium

18
Affective Lability
  • Mood may fluctuate widely in a very short period
    of time (minutes/hours)
  • Anxiety/panic/fear/anger
  • Apathy/sadness - commonly mistaken for depression
  • Euphoria (esp. if steroid-induced)

19
DeliriumDifferential Diagnosis
  • Dementia with Behavioral Disturbance
  • Psychotic Disorder (Schizophrenia)
  • Mood Disorder (Depression, Mania)
  • Catatonia
  • Others

20
Delirium versus Dementia
  • DELIRIUM
  • impaired memory
  • impaired thinking
  • clouding of consciousness
  • major attention deficit
  • fluctuation of course/day
  • disorientation
  • vivid perceptual disturbance
  • incoherent speech
  • disrupt sleep/wake cycle
  • nocturnal exacerbation
  • lack of insight
  • acute or sub acute onset
  • impaired judgment
  • DEMENTIA
  • -
  • -

21
Delirium
  • Generally divided into 4 major types
  • Delirium secondary to general medical condition
  • Delirium secondary to substance intoxication
  • Delirium secondary to substance withdrawal
  • Delirium secondary to multiple etiologies

22
Delirium
  • Rarely is delirium caused by a single factor
    rather, it is a multifactorial syndrome,
    resulting from the interaction of the
    vulnerability on the part of the patient (ie,
    predisposing conditionscognitive impairment,
    severe illness, visual impairment) and
    hospital-related insults (ie, medications and
    procedures). Inouye et al 2007

23
Source Matrix Advocare Network wesite
24
Case 2
  • Consult requested for 85 yo female with h/o
    dementia recently admitted to the SNF, following
    hospitalization for hip fracture/repair ,
    complicated by post-op infection. Pt noted by
    staff to be disoriented, sundowning, and
    resistant to care and PT. Per staff, family
    concerned that her dementia is much worse than
    before her surgery despite apparently successful
    surgery and resolution of her infection.
  • What initial plan would be best?
  • A) Send her to the ER
  • B) Review chart including medication list, talk
    to staff/family, physical and mental status exams
  • C) Begin routine haloperidol 0.5 mg TID for
    agitation
  • D) Begin lorazepam 1 mg with dinner for
    sundowning behaviors

25
Etiologies of Delirium
  • Urgent recognition
  • Wernickes
  • Hypoxia
  • Hypoglycemia
  • Hypertensive encephalopathy
  • Intracerebral hemorrhage
  • Meningitis/encephalitis
  • Poisoning/medications

26
Etiologies - I WATCH DEATH
  • I Infection
  • W Withdrawal
  • A Acute Metabolic
  • T Trauma
  • C CNS Pathology
  • H Hypoxia
  • D Deficiencies (especially vitamin)
  • E Endocrinopathies
  • A Acute Vascular
  • T Toxins
  • H Heavy metals

27
(No Transcript)
28
Etiologies of Delirium
  • General Medical Conditions
  • HIV/AIDS
  • Orthopedic procedures (50)
  • Infectious (UTI, Pneumonia, Sepsis)
  • Metabolic derangement
  • Cancer (PLE, brain metsL, B, M)
  • Impaction, constipation, dehydration, many, many
    others

29
Etiologies of Delirium
  • Iatrogenic and polypharmacy
  • Anticholinergic medications
  • Opioids
  • Benzodiazepines
  • Steroids
  • Antihistamines
  • Antibiotics
  • Many, many others

30
Delirium Neurobiology
  • Best established neurotransmitter dysfunction
    reduced cholinergic activity
  • Increased dopamine may also play a role
  • Low and excessive serotonin
  • Low and excessive GABA
  • Trzepacz and Meagher 2005

31
Delirium Neurobiology
  • Direct injury to the neurons
  • Metabolic
  • Ischemic
  • Alters synthesis/release of neurotransmitters
  • Stress response
  • Trauma, surgery, infection ? release of
    proinflammatory cytokines, elevated cortisol
  • Direct neurotoxic effects
  • Alters neurotransmitter levels
  • Mittal et al 2011

32
Diagnosis of Delirium
  • Delirium is a clinical diagnosis
  • History and physical examination (attention to
    VS)
  • Mental Status Exam
  • Rating Scales-consider on admission
  • Confusion Assessment Method
  • Delirium Rating Scale
  • MMSE/Clock

33
Diagnosis of Delirium
  • Lab tests cannot diagnose delirium but may
    support dx
  • CBC, CMP, UA, urine tox, TSH, B12, ammonia
  • CXR, EKG, LP if indicated
  • Neuroimaging
  • EEG
  • Generalized slowing in delirium, nonspecific
  • Triphasic waves in hepatic encephalopathy
  • Low voltage fast activity in EtOH or BZD w/d

34
Delirium Management
  • Identification and reversal of cause is the
    definitive treatment
  • The search must be thorough, as in the diagnosis
    and treatment of any other organ system failure.
  • Delirium is brain failure!

35
Delirium Management
  • Monitor VS and I/O
  • Ensure good oxygenation
  • D/C nonessential medications
  • Minimize opioids, benzos, etc
  • Repeat PE, further lab, radiologic studies if
    cause not yet identified

36
Delirium Management
  • Behavioral/Environmental Strategies
  • Reorientation, calendars, clocks
  • Room near nursing station
  • Lights on/off during day/night
  • Windows
  • Family/familiarity
  • Hearing aids, glasses
  • Avoid restraints

37
Delirium Management
  • Pharmacological Therapy
  • Nothing FDA-approved
  • Antipsychotics are treatment of choice for
    agitation compromising care or safety
  • Haloperidol best studied, widely used
  • Virtually no anticholinergic effects
  • Virtually no hypotensive effects
  • Risk of EPS (akathisia), rare with IV route

38
Delirium Management
  • Pharmacological Therapy
  • Haloperidol
  • EPS rare when IV route used, however, IV route
    carries risk of QTc prolongation?risk of TdP
  • Risk greatest with higher doses over shorter
    periods of time, in pts with QTc gt450
  • Monitor EKG and electrolytes (K, Mg)
  • Monitor for akathisia

39
Delirium Management
  • Antipsychotic Dosing in Elderly
  • Use clinical judgment depending on severity of
    symptoms for starting dose
  • Haloperidol
  • 0.5mg mild
  • 1mg moderate
  • 2mg severe
  • Assess response to initial dose and repeat as
    needed, monitoring for effectiveness and adverse
    effects
  • Day one order prn
  • Day two and beyond assess total drug needed
    previous day and schedule that amount over the
    next day. Reassess daily continuing process
    until delirium resolves.
  • Once symptoms have remitted, continue effective
    dose for 48 hours, then slowly taper and
    discontinue over 1-5 days, depending on severity
    and duration of delirium up to that point. Avoid
    abrupt discontinuation after first day or two of
    mental clarity to avoid risk of rebound symptoms

40
Delirium Management
  • Atypical Antipsychotics
  • Risperidone 0.25-0.5 po bid prn
  • ODT available
  • Olanzapine 2.5 mg qhs
  • IM/ODT available
  • Caution sedating, anticholinergic
  • Quetiapine 25 mg po bid prn
  • Limited data on aripiprazole, ziprasidone
    (concern for QTc prolongation)

41
Delirium Management
  • Cochrane Review 2007
  • Meta-analysis compared efficacy and adverse
    effects (3 trials included)
  • No difference in efficacy or adverse effects
    between low dose haloperidol and risperidone and
    olanzapine
  • High dose haloperidol (gt4.5 mg/d) greater
    incidence of SE, mainly EPS
  • Lonergan 2007

42
Delirium Management
  • Antipsychotics
  • Black box warning
  • Increased risk of death/CVAEs in pts with
    dementia
  • Use judiciously, continue to reassess R/B ratio,
    taper when appropriate

43
Case 3
  • 70 yo male with no reported psychiatric history
    admitted for elective surgery. Doing well post-op
    until development of acute confusion, agitation,
    paranoia, trying to pull out lines and demanding
    to leave AMA. Exam reveals a diaphoretic,
    tremulous man with tachycardia and elevated BP.
    Which are part of the initial treatment plan?
  • A) Begin olanzapine 5 mg q4h routine for
    agitation
  • B) Transfer directly to psychiatry
  • C) Ensure safety of patient/staff
  • D) Obtain collateral information and history
    from family, review chart/meds, complete physical
    and mental status examinations
  • E) Initiate alcohol detox protocol with
    lorazepam
  • F) Check CMP, CBC, UA, urine tox, ammonia

44
Delirium Management
  • Pharmacological Therapy
  • Benzodiazepines
  • Primarily indicated in EtOH or benzodiazepine
    withdrawal delirium
  • Adjunct to neuroleptics in treatment of severe
    agitation
  • Lorazepam preferred given its reliable absorption
    from po/IM/IV routes
  • Generally avoided as may WORSEN
    delirium--especially hepatic encephalopathy

45
Prognosis
  • Variable
  • Full recovery (unlikely at time of hospital d/c
    in the elderly, may take several weeks)
  • Persistent cognitive deficits (new baseline)
  • Stupor, coma, death (the presence of delirium
    indicates a more serious medical illness,
    affecting the central nervous system)

46
(No Transcript)
47
Prevention
  • 30-40 cases preventable
  • Risk factor intervention (Inouye 1999)
  • Standardized protocols for 6 risk factors
  • Reduced incidence of delirium
  • Decreased total of days and of episodes
  • No difference in
  • Severity of delirium
  • Recurrence of delirium
  • Fong 2009
  • Inouye et al1999

48
Conclusion
  • Delirium is common in the geriatric population
  • Dementia is a risk factor for delirium patients
    frequently have both
  • Recognizing delirium, and distinguishing the
    syndrome from primary psychiatric conditions is
    critical
  • Delirium can present in a variety of ways and can
    be a result of a number of etiologies
  • Awareness of the hypoactive subtype of delirium
    is important avoid confusing it with depression
  • Antipsychotic medications are useful in the
    management of symptoms of delirium
    benzodiazepines are useful in cases of alcohol or
    benzodiazepine withdrawal, only.

49
References
  • Trzepacz PT, Meagher DJ. Delirium. In Levenson
    JL, ed. Textbook of Psychosomatic Medicine.
    Arlington, VA American Psychiatric Publishing,
    200591-130.
  • Saxena S, Lawley D. Delirium in the Elderly a
    clinical review. Postgrad Med J.
    200985(1006)405-413.
  • Fong TG, Tulebaev SR, Inouye SK. Delirium in
    elderly adults diagnosis, prevention and
    treatment. Nat Rev Neurol. 20095(4)210-220.
  • Mittal V, Muralee S, Williamson D, et al.
    Delirium in the elderly a comprehensive review.
    Am J Alzheimers Dis Other Dement. 2011
    Mar26(2)97-109.
  • Siddiqui N, House AO, Holmes JD. Occurrence and
    outcome of delirium in medical in-patients a
    systematic literature review. Age Ageing.
    200635(4)350-364.
  • Lonergan E, Britton AM, Luxenberg J.
    Antipsychotics for delirium. Cochrane Database of
    Systematic Reviews 2007, Issue 2. Art. No.
    CD005594. DOI 10.1002/14651858.CD005594.pub2
  • Inouye SK, Bogardus ST Jt, Charpentier PA, et al.
    A multicomponent intervention to prevent delirium
    in hospitalized older patients. N Engl J Med.
    1999340(9)669-676.
Write a Comment
User Comments (0)
About PowerShow.com